Patients currently undergoing immunosuppressive therapy (phototherapy, or concomitant application of other immunosuppressant agents) should not receive alefacept to avoid the risks of excessive immunosuppression.
The advice is given for patients who are already on immunosuppressive therapies, such as phototherapy and other medications that suppress the immune system, to avoid the risks associated with alefacept use.